Abstract
Although most drugs target proteins, the proteome has remained largely untapped for the discovery of drug targets. The sequencing of the human genome has had a tremendous impact on proteomics and has provided a framework for protein identification. There is currently substantial interest in implementing proteomics platforms for drug target discovery. Although the field is still in the early stages, current proteomic tools include a variety of technologies that could be implemented for large-scale protein expression analysis of cells and tissues, leading to discovery of novel drug targets. Proteomics uniquely allows delineation of global changes in protein expression patterns resulting from transcriptional and post-transcriptional control, post-translational modifications and shifts in proteins between different cellular compartments. Some of the current technologies for proteome profiling and the application of proteomics to the analysis of leukemias by our group are reviewed.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia
Journal of Translational Medicine Open Access 15 January 2009
-
Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigen
BMC Cancer Open Access 14 January 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hanash SM . Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status Electrophoresis 2000 21: 1202–1209
Patterson S . Mass spectrometry and proteomics Physiol Genom 2000 2: 59–65
Bjellqvist B, Ek K, Righetti PG, Gianazza E, Görg A, Westermeier R, Postel W . Isoelectric focusing in immobilized pH gradients: principle, methodology, and some applications J Biochem Biophys Meth 1982 6: 317–339
Strahler JR, Hanash SM, Somerlot L, Görg A, Weser J, Postel W . High resolution two-dimensional polyacrylamide gel electrophoresis of basic polypeptides: use of immobilized pH gradients in the first dimension Electrophoresis 1987 8: 165–173
Slamon DJ, Leyland JB, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L . Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 2001 344: 783–792
Raymond E, Faivre S, Armand JP . Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy Drugs 2000 60 (Suppl. 1): 15–23
Santoni V, Kieffer S, Desclaux D, Masson F, Rabilloud T . Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties Electrophoresis 2000 21: 3329–3344
von Haller P, Donohoe S, Goodlett D, Aebersold R, Watts J . Mass spectrometric characterization of proteins extracted from jurkat T cell detergent-resistant membrane domains Proteomics 2001 1: p 1010–1021
Stoeckli M, Chaurand P, Hallahan D, Caprioli R . Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues Nat Med 2001 7: 493–496
Bussow K, Cahill D, Nietfeld W, Bancroft D, Scherzinger E, Lehrach H, Walter G . A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library Nucleic Acids Res 1998 26: 5007–5008
Lueking A, Horn M, Eickhoff H, Bussow K, Lehrach H, Walter G . Protein microarrays for gene expression and antibody screening Anal Biochem 1999 270: 103–111
Zhu H, Klemic JF, Chang S, Bertone P, Casamayor A, Klemic KG, Smith D, Gerstein M, Reed MA, Snyder M . Analysis of yeast protein kinases using protein chips Nat Genet 2000 26: 283–289
DeWildt R, Mundy C, Gorick B, Tomlinson I . Antibody arrays for high-throughtput screening of antibody-antigen interactions Nat Biotechnol 2001 18: 989–994
Ge H . UPA, a universal protein array system for quantitative detection of protein–protein, protein–DNA, protein–RNA, and protein–ligand interactions Nucleic Acids Res 2000 28: e3
Rowe CA, Scruggs SB, Feldstein MJ, Golden JP, Ligler FS . An array immunosensor for simultaneous detection of clinical analytes Anal Biochem 1999 71: 433–439
Mendoza LG, McQuary P, Mongan A, Gangadharan R, Brignac S, Eggers M . High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA) Biotechniques 1999 27: 778–780, 782–786, 788
Silzel JW, Cercek B, Dodson C, Tsay T, Obremski RJ . Mass-sensing multianalyte microarray immunoassay with imaging detection Clin Chem 1998 44: 2036–2043
Arenkov P, Kukhtin A, Gemmell A, Voloshchuk S, Chupeeva V, Mirzabekov A . Protein microchips: use for immunoassay and enzymatic reactions Anal Biochem 2000 278: 123–131
Haab BB, Dunham MJ, Brown PO . Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions Genome Biol 2001 2: 0004.1–0004.13
MacBeath G, Schreiber SL . Printing proteins as microarrays for high-throughput function determination Science 2000 289: 1760–1763
Schweitzer B, Wiltshire S, Lambert J, O'Malley S, Kukanskis K, Zhu Z, Kingsmore SF, Lizardi PM, Ward DC . Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection Proc Natl Acad Sci USA 2000 97: 10113–10119
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP . Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 1998 4: 844–847
Kallioniemi OP, Wagner U, Kononen J, Sauter G . Tissue microarray technology for high-throughput molecular profiling of cancer Hum Molec Genet 2001 10: 657–662
Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin EF III, Liotta LA . Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front Oncogene 2001 20: 1981–1989
Madoz-Gurpide J, Wang H, Misek D, Hanash S . Protein-based microarrays: a tool for probing the proteome of cancer cells and tissues Proteomics 2001 1: 1279–1287
Schena M, Shalon D, Heller R, Chai A, Brown PO . Quantitative monitoring of gene expression patterns with a complementary microarray Science 1995 270: 467–470
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM . Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 1996 14: 367–370
Madoz-Gurpide J, Abad JM, Fernandez-Recio J, Velez M, Vazquez L, Gomez-Moreno C, Fernandez VM . Modulation of electroenzymatic NADPH oxidation through oriented immobilization of ferredoxin: NADP(+) reductase onto modified gold electrodes J Am Chem Soc 2000 122: 9808–9817
Delamarche E, Sundarababu G, Biebuyck H, Michel B, Gerber C, Sigrist H, Wolf H, Ringsdorf H, Xanthopoulos N, Mathieu HJ . Immobilization of antibodies on a photoactive self-assembled monolayer on gold Langmuir 1996 12: 1997–2006
Muller W, Ringsdorf H, Rump E, Wildburg G, Zhang X, Angermaier L, Knoll W, Liley M, Spinke J . Attempts to mimic docking processes of the immune system: recognition-induced formation of protein multilayers Science 1993 262: 1706–1708
Hanash SM, Baier LJ, McCurry L, Schwartz S . Lineage related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional electrophoresis Proc Natl Acad Sci USA 1986 83: 807–811
Hanash SM, Baier LJ, Neel JV, Niezgoda W . Genetic analysis of thirty three platelet polypeptides detected in two-dimensional polyacrylamide gels Am J Hum Genet 1986 38: 352–360
Reaman G, Zeltzer P, Bleyer WA, Amendola B, Level C, Sather H, Hammond D . Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group J Clin Oncol 1985 3: 1513–1521
Crist W, Pullen J, Boyett J, Falletta J, van Eys J, Borowitz M, Jackson J, Dowell B, Frankel L, Quddus F, Ragab A, Vietti T . Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group study Blood 1986 67: 135–140
Hanash SM, Kuick R, Strahler JR, Richardson BC, Reaman G, Stoolman L, Hanson C, Nichols D, Tueche J . Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children Blood 1989 73: 527–532
Strahler JR, Kuick R, Eckerskorn C, Lottspeich F, Richardson BC, Fox DA, Stoolman LM, Hanson CA, Nichols D, Tueche HJ, Hanash SM . Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins J Clin Invest 1990 85: 200–207
Voss T, Ahorn H, Haberl P, Dohner H, Wilgenbus K . Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia Int J Cancer 2001 91: 180–186
Zhu XX, Kozarsky K, Strahler JR, Eckerskorn C, Lottspeich F, Melhem R, Lowe J, Fox DA, Hanash SM, Atweh GF . Molecular cloning of a novel human leukemia associated gene: evidence of conservation in animal species J Biol Chem 1989 264: 14556–14560
Metz CE, Herman BA, Shen J . Maximum likelihood estimation of receiver operating characteristics (ROC) curves from continuously distributed data Stat Med 1998 24: 467–478
Melhem RF, Zhu XX, Hailat N, Strahler J, Hanash SM . Characterization of the gene for a proliferation related phosphoprotein (Op18) expressed in high amounts in acute leukemia J Biol Chem 1991 266: 17747–17753
Hailat N, Strahler J, Melhem R, Zhu X-X, Brodeur G, Seeger RC, Reynolds CP, Hanash SM . N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18) Oncogene 1990 5: 1615–1618
Melhem R, Hailat N, Kuick R, Hanash SM . Quantitative analysis of Op18 phosphorylation in childhood acute leukemia Leukemia 1997 11: 1690–1695
Belmont LD, Mitchison TJ . Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules Cell 1996 84: 623–631
Jourdain L, Curmi P, Sobel A, Pantaloni D, Carlier MF . Stathmin: a tubulin-sequencing protein which forms a ternary T2S complex with two tubulin molecules Biochem 1997 36: 10817–10821
Larsson N, Marklund U, Gradin HM, Brattsand G, Gullberg M . Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis Mol Cell Biochem 1997 17: 5530–5539
Horwitz SB, Shen HJ, He L, Dittmar P, Neef R, Chen J, Schubart UK . The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation J Biol Chem 1997 272: 8129–8132
Rowlands DC, Williams A, Jones NA, Guest SS, Reynolds GM, Barber PC, Brown G . Stathmin expression is a feature of proliferating cells of most if not all cell lineages Lab Invest 1995 72: 100–113
Cooper HL, McDuffie E, Braverman R . Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein prosolin J Immunol 1989 143: 956–963
Strahler JR, Lamb BJ, Ungar DR, Fox DA, Hanash SM . Cell cycle progression is associated with distinct patterns of phosphorylation of Op18 Biochem Biophys Res Commun 1992 185: 197–203
Strahler JR, Hailat N, Lamb BJ, Rogers KP, Underhill JA, Melhem RF, Keim DR, Zhu X-X, Kuick RD, Fox DA, Hanash SM . Activation of resting peripheral blood lymphocytes through the T cell receptor induces rapid phosphorylation of Op18 J Immunol 1992 149: 1191–1198
Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A . The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network J Cell Sci 1998 111: 3333–3346
Beretta L, Dobránsky T, Sobel A . Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2 J Biol Chem 1993 268: 20076–20084
Larsson N, Melander H, Marklund U, Osterman Ö, Gullberg M . G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems J Biol Chem 1995 23: 14175–14183
Marklund U, Brattsand G, Shingler V, Gullberg M . Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase J Biol Chem 1993 268: 15039–15047
Marklund U, Larsson N, Brattsand G, Osterman O, Chatila TA, Gullberg M . Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr Eur J Biochem 1994 225: 53–60
Curmi PA, Maucuer A, Asselin S, Lecourtois M, Chaffotte A, Schmitter JM, Sobel A . Molecular characterization of human stathmin expressed in Escherichia coli: site-directed mutagenesis of two phosphorylatable serines (Ser-25 and Ser-63) Biochem J 1994 300: 331–338
Sobel A . Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem Sci 1991 16: 301–305
Marklund U, Larsson N, Gradin HM, Brattsand G, Gullberg M . Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics EMBO J 1996 15: 5290–5298
Hanash SM, Strahler JR, Kuick R, Chu EHY, Nichols D . Identification of a polypeptide associated with the malignant phenotype in acute leukemia J Biol Chem 1988 263: 12813–12815
Roos G, Brattsand G, Landberg G, Marklund U, Gullberg M . Expression of oncoprotein 18 in human leukemias and lymphomas Leukemia 1993 7: 1538–1546
Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nanberg E, Sideras P, Gullberg M . Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells Leukemia 1993 7: 569–579
Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R, Bieche I . Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours Br J Cancer 2000 82: 42–50
Misek D, Chang C, Kuick R, Hinderer R, Giordano T, Beer D, Hanash S . Oncogenic mutation of the microtubule regulator Op18 J Biol Chem 2001 (submitted)
Melhem RF, Strahler JR, Hailat N, Zhu XX, Hanash SM . Involvement of Op18 in cell proliferation Biochem Biophys Res Commun 1991 179: 1649–1655
Jeha S, Luo X-N, Beran M, Kantarjian H, Atweh GF . Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells Cancer Res 1996 56: 1445–1450
Nishio K, Nakamura T, Koh Y, Kanzawa F, Tamura T, Saijo N . Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells Cancer 2001 91: 1491–1499
Mistry S, Atweh G . Stathmin inhibition enhances okadaic acid-induced mitotic arrest. A potential role for stathmin in mitotic exit J Biol Chem 2001 276: 31209–31215
Packer N . Post-translational modifications Proteomics 2001 1: 167–364
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanash, S., Madoz-Gurpide, J. & Misek, D. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16, 478–485 (2002). https://doi.org/10.1038/sj.leu.2402412
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402412
Keywords
This article is cited by
-
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia
Journal of Translational Medicine (2009)
-
Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigen
BMC Cancer (2009)
-
Disease proteomics toward bedside reality
Journal of Gastroenterology (2005)
-
Disease proteomics
Nature (2003)
-
New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies
Pathology & Oncology Research (2002)